Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Effect of protamine in obesity induced by high-fat diets in rats

International Journal of Obesity volume 33, pages 687–692 (2009)Cite this article

Abstract

Objective:

Protamine has been shown to have an inhibitory effect on protein lipase in vitro; the objective of this study was to evaluate the antiobesity activity effect of protamine in obese induced rats, and to evaluate the effect of protamine on postprandial hypertriacylglyceridemia in rats by intragastric administration of a lipid emulsion containing corn oil.

Design:

Two experiments were carried out: (1) In a parallel study in rats, we administered a lipid emulsion containing corn oil plus 0, 200 or 500 mg kg–1 of protamine intragastrically. (2) In a randomized parallel prospective rats experiment, rats were fed with a high-fat diet and 0, 200 or 500 mg of protamine per kg of animal weight during 5 weeks.

Subjects:

Male Sprague–Dawley rats.

Measurements:

In experiment 1, plasma triacylglycerol levels after oral administration of lipid emulsion were determined. In experiment 2, weight gain, concentrations of plasma triacylglycerol, plasma total cholesterol and albumin were determined, and the subcutaneous and visceral adipose tissues were weighed.

Results:

Plasma triacylglycerol concentration in rats administered with 200 or 500 mg kg–1 of protamine was significantly lower than that in rats in the control group (200 mg kg–1 of protamine, P<0.05 at 1, 2, 3 and 4 h; 500 mg kg–1 of protamine P<0.05 at 2, 3 and 4 h). In rats fed with a high-fat diet, and 200 and 500 mg kg–1 of protamine, there was a decreased body weight gain by 52 and 66 g, respectively, reduced visceral fat by 5 and 8 g, respectively and subcutaneous tissue weights by 12 and 15 g, respectively. Plasma triacylglycerol was 17 and 45 mg per 100 ml lower in rats fed with high-fat diet plus 200 and 500 mg kg–1 of protamine, respectively. And cholesterol concentrations were 18 and 22 mg per 100 ml lower in both protamine groups, respectively.

Conclusion:

Our study demonstrates that protamine reduce weight gain and body fat accumulation through the inhibition of dietary fat absorption.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157–163.

    Article  Google Scholar 

  2. Kopelman PG . Obesity as a medical problem. Nature 2000; 404: 635–643.

    Article  CAS  Google Scholar 

  3. Salvador J, Silva C, Santos E . Pharmacological treatment of obesity. An Sist Sanit Navar 2002; 25: 143–161.

    PubMed  Google Scholar 

  4. Weigle D . Pharmacological therapy of obesity: past, present and future. J Clinl Endocrinol Metab 2003; 88: 2462–2469.

    Article  CAS  Google Scholar 

  5. Luque CA, Rey JA . The discovery and status of sibutramine as an anti-obesity drug. Eur J Pharmacol 2002; 440: 119–128.

    Article  CAS  Google Scholar 

  6. Hill JO, Hauptman J, Anderson JW, Fujioka K, O'Neil PM, Smith DK et al. Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study. Am J Clin Nutr 1999; 69: 1108–1116.

    Article  CAS  Google Scholar 

  7. Drew BS, Dixon AF, Dixon JB . Obesity management: update on orlistat. Vasc Health Risk Manag 2007; 3: 817–821.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Han LK, Xu BJ, Kimura Y, Zheng Y, Okuda H . Platycodi radix affects lipid metabolism in mice with high fat diet-induced obesity. J Nutr 2000; 130: 2760–2764.

    Article  CAS  Google Scholar 

  9. Yoshikawa M, Ninomiya K, Shimoda H, Nishida N, Matsuda H . Hepatoprotective and antioxidative properties of Salacia reticulata: preventive effects of phenolic constituents on CCl4-induced liver injury in mice. Biol Pharm Bull 2002; 25: 72–76.

    Article  CAS  Google Scholar 

  10. Satouchi K, Kodama Y, Murakami K, Tanaka T, Iwamoto H, Ishimoto M . A lipase-inhibiting protein from lipoxygenase-deficient soybean seeds. Biosci Biotechnol Biochem 2002; 66: 2154–2160.

    Article  CAS  Google Scholar 

  11. Tani H, Ohishi H, Watanabe K . Purification and characterization of proteinous inhibitor of lipase from wheat flour. J Agric Food Chem 1994; 42: 2382–2385.

    Article  CAS  Google Scholar 

  12. Tsujita T, Matsuura Y, Okuda H . Studies on the inhibition of pancreatic and carboxylester lipases by protamine. J Lipid Res 1996; 37: 1481–1487.

    CAS  PubMed  Google Scholar 

  13. Ando T, Yamasaki M, Suzuki K . Protamines: isolation, characterization, structure and function. Mol Biol Biochem Biophys 1973; 12: 1–114.

    Article  CAS  Google Scholar 

  14. Birari RB, Bhutani KK . Pancreatic lipase inhibitors from natural sources: unexplored potential. Drug Discov Today 2007; 12: 879–889.

    Article  CAS  Google Scholar 

  15. Rosado JL, García-Padilla S, Duarte-Vázquez MA . Composition for the treatment of obesity and hiperlipidemia. PCT/MX2005/000058, 2004.

  16. Koopman R, Schaart G, Hesselink MKC . Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids. Histochem Cell Biol 2001; 116: 63–68.

    CAS  Google Scholar 

  17. Tani H, Ohishi H, Watanabe K . When flour lipase inhibitor decreases serum lipid levels in male rats. J Nutr Sci Vitaminol (Tokyo) 1995; 41: 699–706.

    Article  CAS  Google Scholar 

  18. Kido Y, Hiramoto S, Murao M, Horio Y, Miyazaki T, Kodama T et al. Epsilon-polylysine inhibits pancreatic lipase activity and suppresses postprandial hypertriacylglyceridemia in rats. J Nutr 2003; 133: 1887–1891.

    Article  CAS  Google Scholar 

  19. Carey MC, Small DM, Bliss CM . Lipid digestion and absorption. Annu Rev Physiol 1983; 45: 651–677.

    Article  CAS  Google Scholar 

  20. Bergstrom RW, Newell-Morris LL, Leonetti DL, Shuman WP, Wahl PW, Fujimoto WY . Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes 1990; 39: 104–111.

    Article  CAS  Google Scholar 

  21. Hoeg JM, Maher MB, Bailey KR, Brewer Jr HB . The effects of mevinolin and neomycin alone and in combination on plasma lipid and lipoprotein concentrations in type II hyperlipoproteinemia. Atherosclerosis 1986; 60: 209–214.

    Article  CAS  Google Scholar 

  22. Farnsworth WH, Hoeg JM, Maher M, Brittain EH, Sherins RJ, Brewer Jr HB . Testicular function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin) or neomycin. J Clin Endocrinol Metab 1987; 65: 546–550.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The study was partially supported by CONACYT-Secretaria de Economía, México, Grant NO. ECO-2003-16076. Thanks are given to the Human Nutrition Group of the Universidad Autónoma de Querétaro for allowing us the utilization of their facilities.

Author information

Authors and Affiliations

  1. NUCITEC S.A. de C.V. Comerciantes 15-3, Colonia Peñuelas, Querétaro, México

    MÁ Duarte-Vázquez & R De la Cruz-Cordero

  2. CINDETEC, Centro de Investigación y Desarrollo Tecnológico en Enfermedades Crónicas, Júrica 122, Parque Industrial Querétaro, Querétaro, México

    MÁ Duarte-Vázquez, S García-Padilla, L Olvera-Ochoa, K E González-Romero, J Acosta-Íñiguez & J L Rosado

  3. Facultad de Ciencias Naturales, Universidad Autónoma de Querétaro, Avenida de las Ciencias S/N, Juriquilla, Querétaro, México,

    L Olvera-Ochoa, J Acosta-Íñiguez & J L Rosado

Authors
  1. MÁ Duarte-Vázquez
    View author publications

    Search author on:PubMed Google Scholar

  2. S García-Padilla
    View author publications

    Search author on:PubMed Google Scholar

  3. L Olvera-Ochoa
    View author publications

    Search author on:PubMed Google Scholar

  4. K E González-Romero
    View author publications

    Search author on:PubMed Google Scholar

  5. J Acosta-Íñiguez
    View author publications

    Search author on:PubMed Google Scholar

  6. R De la Cruz-Cordero
    View author publications

    Search author on:PubMed Google Scholar

  7. J L Rosado
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to J L Rosado.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Duarte-Vázquez, M., García-Padilla, S., Olvera-Ochoa, L. et al. Effect of protamine in obesity induced by high-fat diets in rats. Int J Obes 33, 687–692 (2009). https://doi.org/10.1038/ijo.2009.78

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/ijo.2009.78

Keywords

This article is cited by

Search

Advanced search

Quick links